SALT LAKE CITY, July 18, 2016 – Clinical Innovations, a member of Pritzker Group Private Capital’s family of companies and the largest medical device company exclusively focused on labor and delivery, today announced the appointment of Glenn Weatherley as vice president and managing director of Clinical Innovations Europe.

As a certified biomedical scientist with nearly four decades of international experience in the biomedical sciences and medical device and diagnostic industries, Weatherley brings a strong track record of successfully driving growth and business development across several medical markets, including surgery and women’s health. In his new role, he is responsible for leading the Clinical Innovations Europe team and strategy for its growing list of European distribution partners.

Most recently, Weatherley was vice president of international markets for Insulet Corporation, overseeing marketing initiatives and distribution operations for Europe and Canada. From 2008 to 2014, he was vice president of sales for Hologic’s European diagnostic franchise, driving annual revenues of nearly $120 million. Before that, he held business development, sales management and clinical support positions throughout the U.K., Ireland and the Netherlands with Cytyc Corporation, a women’s clinical product manufacturer, and NeuroMedical Systems, a healthcare technology company.

Before transitioning to medical device distribution and business development, Weatherley spent 17 years in biomedical science specializing in laboratory diagnostics and cellular pathology at Dryburn Hospital Durham and Newcastle General Hospital.

Weatherley was a member of the prestigious International Academy of Cytology and attended the University of Northumbria, where he earned a Higher National Certificate in Biomedical Sciences.

“Glenn is a proven medical sales and distribution leader with an extensive background in the biomedical sciences that truly fits with our mission to improve the lives of mothers and their babies throughout the world,” said Steve Cash, senior vice president of global sales for Clinical Innovations. “His top-down understanding of the industry and leadership in the European market is invaluable for our continued global growth and ongoing research, development and manufacturing of innovative, industry-changing medical devices.”

About Clinical Innovations

Clinical Innovations is the largest medical device company exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter; Kiwi® Vacuum-Assisted Delivery System; ROM Plus® Rupture of Membranes Test; traxi® Panniculus Retractor and ClearView Uterine Manipulator. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. For more information, visit

About Pritzker Group

Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets.

Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies.

For more information, visit